Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4422712)

Published in PLoS One on May 06, 2015

Authors

Rong Yao1, Yu Cao1, Ya-rong He1, Wayne Bond Lau2, Zhi Zeng1, Zong-an Liang3

Author Affiliations

1: Emergency Medicine Department, West China Hospital, Sichuan University, 37 Guoxue Road, Chengdu, Sichuan, 610041, PR China.
2: Emergency Medicine Department of Thomas Jefferson University Hospital, 1025 Walnut Street, 808 College Building, Philadelphia, PA, 19107, United States of America.
3: Respiratory Department, West China Hospital, Sichuan University, 37 Guoxue Road, Chengdu, Sichuan, 610041, PR China.

Articles cited by this

Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol (1988) 5.16

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab (2002) 4.64

The myofibroblast in pulmonary fibrosis. Chest (2002) 3.46

Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest (2007) 3.16

Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol (2003) 2.95

Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol (2008) 2.91

The role of transforming growth factor beta in lung development and disease. Chest (2004) 2.83

Role of antioxidants in paraquat toxicity. Toxicology (2002) 2.70

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology (2003) 2.53

Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) (2006) 2.31

Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc (2006) 1.89

Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol (2004) 1.70

Ski and SnoN: negative regulators of TGF-beta signaling. Curr Opin Genet Dev (2004) 1.69

Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease. Fibrogenesis Tissue Repair (2011) 1.61

Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. Am J Physiol Lung Cell Mol Physiol (2006) 1.46

Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler Thromb Vasc Biol (2008) 1.39

siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther (2007) 1.39

Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol (2007) 1.35

Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal (2009) 1.33

p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci (2006) 1.28

Histopathology of pulmonary fibrotic disorders. Semin Respir Crit Care Med (2006) 1.26

Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care (2011) 1.19

Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech (2014) 1.16

Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol (2003) 1.12

The role of fibrocytes in fibrotic diseases of the lungs and heart. Fibrogenesis Tissue Repair (2011) 1.10

A long-term follow-up of lung function in survivors of paraquat poisoning. Hum Exp Toxicol (2000) 1.05

Putrescine and paraquat uptake in human lung slices and isolated type II pneumocytes. Biochem Pharmacol (1994) 0.86

Pleiotropism of adiponectin: inflammation, neovascularization, and fibrosis. Circ Res (2009) 0.83

IL-1β suppresses TGF-β-mediated myofibroblast differentiation in cardiac fibroblasts. Growth Factors (2013) 0.82